{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:23:16Z","timestamp":1787296996281,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41417-020-0197-4","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T19:10:32Z","timestamp":1595877032000},"page":"813-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["RETRACTED ARTICLE: Downregulation of SBF2-AS1 functions as a\n            tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted\n            ETS1"],"prefix":"10.1038","volume":"28","author":[{"given":"Xiuqin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4879-5792","authenticated-orcid":false,"given":"Haiying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"197_CR1","first-page":"1555","volume":"28","author":"R Montironi","year":"2013","unstructured":"Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L.\n                    Update on selected renal cell tumors with clear cell features. With emphasis on\n                    multilocular cystic clear cell renal cell carcinoma. Histol Histopathol.\n                    2013;28:1555\u201366.","journal-title":"Histol Histopathol"},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.juro.2008.10.069","volume":"181","author":"BR Lane","year":"2009","unstructured":"Lane BR, Li J, Zhou M, Babineau D, Faber P, Novick AC, et al.\n                    Differential expression in clear cell renal cell carcinoma identified by gene\n                    expression profiling. J Urol. 2009;181:849\u201360.","journal-title":"J Urol."},{"key":"197_CR3","first-page":"101042831769837","volume":"39","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Xu J, Zhu Y, Liu L. The long noncoding RNA\n                    urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker\n                    in clear cell renal cell carcinoma. Tumour Biol.\n                    2017;39:1010428317698377.","journal-title":"Tumour Biol."},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopha.2017.10.149","volume":"97","author":"AM Kabel","year":"2018","unstructured":"Kabel AM, Atef A, Estfanous RS. Ameliorative potential of\n                    sitagliptin and\/or resveratrol on experimentally-induced clear cell renal cell\n                    carcinoma. Biomed Pharmacother. 2018;97:667\u201374.","journal-title":"Biomed Pharmacother."},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","volume":"339","author":"X Shi","year":"2013","unstructured":"Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new\n                    frontier in the study of human diseases. Cancer Lett.\n                    2013;339:159\u201366.","journal-title":"Cancer Lett."},{"key":"197_CR6","first-page":"3031","volume":"20","author":"QS Zhao","year":"2016","unstructured":"Zhao QS, Li L, Zhang L, Meng XW, Li LL, Ge XF, et al.\n                    Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression\n                    and poor prognosis in patients with non-small cell lung cancer. Eur Rev Med\n                    Pharm Sci. 2016;20:3031\u20134.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-016-0352-9","volume":"35","author":"J Lv","year":"2016","unstructured":"Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J, et al. High expression of\n                    long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung\n                    cancer. J Exp Clin Cancer Res. 2016;35:75.","journal-title":"J Exp Clin Cancer Res"},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/21691401.2019.1577883","volume":"47","author":"F Gao","year":"2019","unstructured":"Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. LncRNA SBF2-AS1 promotes\n                    the progression of cervical cancer by regulating miR-361-5p\/FOXM1 axis. Artif\n                    Cells Nanomed Biotechnol. 2019;47:776\u201382.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1002\/jcp.28509","volume":"234","author":"G Chen","year":"2019","unstructured":"Chen G, Gu Y, Han P, Li Z, Zhao JL, Gao MZ. Long noncoding rna\n                    sbf2-as1 promotes colorectal cancer proliferation and invasion by inhibiting\n                    mir-619-5p activity and facilitating hdac3 expression. J Cell Physiol.\n                    2019;234:18688\u201396.","journal-title":"J Cell Physiol"},{"key":"197_CR10","first-page":"5071","volume":"15","author":"R Chen","year":"2018","unstructured":"Chen R, Xia W, Wang X, Qiu M, Yin R, Wang S, et al. Upregulated\n                    long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell\n                    carcinoma. Oncol Lett. 2018;15:5071\u201380.","journal-title":"Oncol Lett"},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA\n                    crosstalk and competition. Nature. 2014;505:344\u201352.","journal-title":"Nature."},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.ircmb.2017.05.001","volume":"333","author":"S Barbato","year":"2017","unstructured":"Barbato S, Solaini G, Fabbri M. MicroRNAs in oncogenesis and tumor\n                    suppression. Int Rev Cell Mol Biol. 2017;333:229\u201368.","journal-title":"Int Rev Cell Mol Biol"},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3892\/ijo.2015.3114","volume":"47","author":"Y Jin","year":"2015","unstructured":"Jin Y, Zhao M, Xie Q, Zhang H, Wang Q, Ma Q. MicroRNA-338-3p\n                    functions as tumor suppressor in breast cancer by targeting SOX4. Int J Oncol.\n                    2015;47:1594\u2013602.","journal-title":"Int J Oncol"},{"key":"197_CR14","first-page":"2195","volume":"16","author":"Y Huang","year":"2018","unstructured":"Huang Y, Wu Y, Zeng L, Shan W, Huang L. The tumor suppressor role\n                    of microRNA-338-3p in renal cell carcinoma. Oncol Lett.\n                    2018;16:2195\u2013200.","journal-title":"Oncol Lett."},{"key":"197_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bbrc.2019.01.006","volume":"509","author":"W Zhao","year":"2019","unstructured":"Zhao W, Zhang S, Wang X, Ma X, Huang B, Chen H, et al. ETS1 targets\n                    RYBP transcription to inhibit tumor cell proliferation. Biochem Biophys Res\n                    Commun. 2019;509:810\u201316.","journal-title":"Biochem Biophys Res Commun"},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.bbrc.2015.04.075","volume":"461","author":"N Ma","year":"2015","unstructured":"Ma N, Chen F, Shen SL, Chen W, Chen LZ, Su Q, et al.\n                    MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion\n                    via targeting ETS1. Biochem Biophys Res Commun.\n                    2015;461:618\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1158\/0008-5472.CAN-10-2435","volume":"71","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, et al. miR-125b is\n                    methylated and functions as a tumor suppressor by regulating the ETS1\n                    proto-oncogene in human invasive breast cancer. Cancer Res.\n                    2011;71:3552\u201362.","journal-title":"Cancer Res."},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy\u2013analysis of\n                    Affymetrix GeneChip data at the probe level. Bioinformatics.\n                    2004;20:307\u201315.","journal-title":"Bioinformatics."},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing\n                    differential expression in microarray experiments. Stat Appl Genet Mol Biol.\n                    2004;3:3.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"197_CR20","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.7150\/jca.19953","volume":"8","author":"Y Xie","year":"2017","unstructured":"Xie Y, Ma X, Li H, Gao Y, Gu L, Chen L, et al. Prognostic value of\n                    clinical and pathological features in chinese patients with chromophobe renal\n                    cell carcinoma: a 10-year single-center study. J Cancer.\n                    2017;8:3474\u201379.","journal-title":"J Cancer."},{"key":"197_CR21","doi-asserted-by":"crossref","unstructured":"Santiago JM, Sasako M, Osorio J. TNM-7th edition 2009 (UICC\/AJCC)\n                    and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and\n                    standardisation in the management of gastric cancer. Cir Esp.\n                    2011;89:275\u201381.","DOI":"10.1016\/S2173-5077(11)70035-7"},{"key":"197_CR22","doi-asserted-by":"publisher","unstructured":"Li G, Xie ZK, Zhu DS, Guo T, Cai QL, Wang Y. KIF20B promotes the\n                    progression of clear cell renal cell carcinoma by stimulating cell\n                    proliferation. J Cell Physiol. 2019. https:\/\/doi.org\/10.1002\/jcp.28322.","DOI":"10.1002\/jcp.28322"},{"key":"197_CR23","doi-asserted-by":"publisher","unstructured":"Zeng MH, Qiu JG, Xu Y, Zhang XH. IDUA, NDST1, SAP30L, CRYBA4, and\n                    SI as novel prognostic signatures clear cell renal cell carcinoma. J Cell\n                    Physiol. 2019. https:\/\/doi.org\/10.1002\/jcp.28297.","DOI":"10.1002\/jcp.28297"},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1080\/21691401.2019.1608221","volume":"47","author":"YJ Tian","year":"2019","unstructured":"Tian YJ, Wang YH, Xiao AJ, Li PL, Guo J, Wang TJ, et al. Long\n                    noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding\n                    with miR-188-5p in acute myeloid leukemia. Artif Cells Nanomed Biotechnol.\n                    2019;47:1730\u201337.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"197_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnmol.2017.00301","volume":"10","author":"H Yu","year":"2017","unstructured":"Yu H, Zheng J, Liu X, Xue Y, Shen S, Zhao L, et al. Transcription\n                    factor NFAT5 promotes glioblastoma cell-driven angiogenesis via\n                    SBF2-AS1\/miR-338-3p-mediated EGFL7 expression change. Front Mol Neurosci.\n                    2017;10:301.","journal-title":"Front Mol Neurosci"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.omtn.2019.04.004","volume":"16","author":"R Chen","year":"2019","unstructured":"Chen R, Xia W, Wang S, Xu Y, Ma Z, Xu W, et al. Long noncoding RNA\n                    SBF2-AS1 is critical for tumorigenesis of early-stage lung adenocarcinoma. Mol\n                    Ther Nucleic Acids. 2019;16:543\u201353.","journal-title":"Mol Ther Nucleic Acids"},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1158\/1541-7786.MCR-13-0507","volume":"12","author":"B Guo","year":"2014","unstructured":"Guo B, Liu L, Yao J, Ma R, Chang D, Li Z, et al. miR-338-3p\n                    suppresses gastric cancer progression through a PTEN-AKT axis by targeting\n                    P-REX2a. Mol Cancer Res. 2014;12:313\u201321.","journal-title":"Mol Cancer Res"},{"key":"197_CR28","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.18632\/oncotarget.2975","volume":"6","author":"L Yu","year":"2015","unstructured":"Yu L, Shang ZF, Hsu FM, Zhang Z, Tumati V, Lin YF, et al. NSCLC\n                    cells demonstrate differential mode of cell death in response to the combined\n                    treatment of radiation and a DNA-PKcs inhibitor. Oncotarget.\n                    2015;6:3848\u201360.","journal-title":"Oncotarget."},{"key":"197_CR29","first-page":"3604","volume":"19","author":"B Cao","year":"2019","unstructured":"Cao B, Tan S, Tang H, Chen Y, Shu P. miR5125p suppresses\n                    proliferation, migration and invasion, and induces apoptosis in nonsmall cell\n                    lung cancer cells by targeting ETS1. Mol Med Rep.\n                    2019;19:3604\u201314.","journal-title":"Mol Med Rep."},{"key":"197_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4149\/neo_2014_054","volume":"61","author":"V Puzovic","year":"2014","unstructured":"Puzovic V, Brcic I, Ranogajec I, Jakic-Razumovic J. Prognostic\n                    values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer\n                    patients. Neoplasma. 2014;61:439\u201346.","journal-title":"Neoplasma."},{"key":"197_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1620\/tjem.213.41","volume":"213","author":"E Yamaguchi","year":"2007","unstructured":"Yamaguchi E, Nakayama T, Nanashima A, Matsumoto K, Yasutake T,\n                    Sekine I, et al. Ets-1 proto-oncogene as a potential predictor for poor\n                    prognosis of lung adenocarcinoma. Tohoku J Exp Med.\n                    2007;213:41\u201350.","journal-title":"Tohoku J Exp Med"},{"key":"197_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/15384047.2018.1529124","volume":"20","author":"H Wang","year":"2019","unstructured":"Wang H, Chen W, Yang P, Zhou J, Wang K, Tao Q. Knockdown of\n                    linc00152 inhibits the progression of gastric cancer by regulating\n                    microRNA-193b-3p\/ETS1 axis. Cancer Biol Ther. 2019;20:461\u201373.","journal-title":"Cancer Biol Ther"},{"key":"197_CR33","first-page":"1986","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yan R, Zhang SN, Zhang HZ, Ruan XJ, Cao Z, et al.\n                    MicroRNA-338-3p inhibits the progression of bladder cancer through regulating\n                    ETS1 expression. Eur Rev Med Pharm Sci. 2019;23:1986\u201395.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"197_CR34","first-page":"2385","volume":"21","author":"Q Sun","year":"2017","unstructured":"Sun Q, Jiang CW, Tan ZH, Hou LY, Dong H, Liu K, et al. MiR-222\n                    promotes proliferation, migration and invasion of lung adenocarcinoma cells by\n                    targeting ETS1. Eur Rev Med Pharm Sci. 2017;21:2385\u201391.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"197_CR35","doi-asserted-by":"publisher","first-page":"64106","DOI":"10.18632\/oncotarget.19329","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Wang C, Li H, Niu X, Liu X, Pei D, et al. miR-338-3p\n                    inhibits the invasion of renal cell carcinoma by downregulation of ALK5.\n                    Oncotarget. 2017;8:64106\u201313.","journal-title":"Oncotarget."}],"updated-by":[{"DOI":"10.1038\/s41417-026-01061-4","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000}}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-0197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-0197-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-0197-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:33:32Z","timestamp":1787294012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-0197-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41417-020-0197-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41417-026-01061-4","URL":"https:\/\/doi.org\/10.1038\/s41417-026-01061-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was performed with the approval of the ethics committee\n                    of Linyi People\u2019s Hospital and guided by the Declaration of Helsinki. All\n                    participants signed the informed consent documentations. Animal experiments were\n                    approved by the Institutional Animal Care and Use Committee of Linyi People\u2019s\n                    Hospital. Efforts were made to avoid all unnecessary distress to the\n                    animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}